| Revenue growth | Q2 +26.7% YoY; existing centres ~20%. |
|---|---|
| Margins | EBITDA margin 44.1%, +355 bps YoY; PAT margin 23.3%. |
| Demand visibility | Wellness testing growth 27.1% Q2; Tier-2/3 scaling. |
| Management confidence | CEO: 'sustained strong growth momentum'. |
Growth
Q2 revenue +26.7% YoY, EBITDA +37.8%, PAT +37.4%. H1 FY27 revenue +24.8%, PAT +37.5%.
Outlook
No numeric growth guidance. 3 hubs+7 spokes H2 FY27; 3 hubs Q1 FY28. Arya Wellness Guwahati ₹46.2 Cr, 8-9x EBITDA.
Risks
Finance costs +45.4% YoY; other expenses +20.4%; no explicit risks flagged beyond standard safe-harbour.
Last quarter's promises, checked
Delivered
- Guided EBITDA margin above 40% (40-45% range) → delivered 44.1% (= BEAT)
- Guided high double-digit FY27 growth → H1 FY27 revenue +24.8% (= BEAT)
Partly delivered
- Guided 9 hubs + 10-12 spokes in 12 months → now 3 hubs + 7 spokes in H2 FY27 and 3 hubs in Q1 FY28 (= PARTIAL)
Investor Presentation filed with BSE, NSE: VIJAYA. Summary written with AI assistance from the document.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,447.10
- Market cap
- ₹14,905 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 79.5×Sector 53.8×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vijaya Diagnostic Centre Ltd
All →Vijaya Diagnostic Centre Results Update
Vijaya Diagnostic's Q2 FY27 press release reports revenue up 26.7% and PAT up 37.4% year-on-year. It also notes an agreement to acquire Arya Wellness Centre in Guwahati.
Vijaya Diagnostic Centre Management Change
Vijaya Diagnostic Centre appointed Rahul Jain as Company Secretary and Compliance Officer, designated KMP, effective November 03, 2026. The appointment follows the Nomination and Remuneration Committee's recommendation.
Vijaya Diagnostic Centre Q2 FY27 Results: Net Profit ₹59.5 Cr, Up 37.4% YoY
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹255.4 Cr (+26.7% YoY) and net profit of ₹59.5 Cr (+37.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹59.5 Cr · +37.4% YoY
Vijaya Diagnostic Centre Board Meeting Date
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.
Vijaya Diagnostic Centre Other Announcement
Vijaya Diagnostic Centre Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This report details the share distribution among various shareholder categories.
Vijaya Diagnostic Centre Annual General Meeting
Vijaya Diagnostic Centre held its 24th Annual General Meeting on September 24, 2026. Shareholders transacted ordinary and special business, including declaring a final dividend.